Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹91 Cr
Revenue (TTM)
₹84 Cr
Net Profit (TTM)
₹16 Cr
ROE
40.6 %
ROCE
33.8 %
P/E Ratio
5.7
P/B Ratio
0.8
Industry P/E
47.23
EV/EBITDA
4.1
Div. Yield
0 %
Debt to Equity
0.7
Book Value
₹34.9
EPS
₹11.8
Face value
10
Shares outstanding
17,420,000
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Star Imaging and Path Lab
| -42.3 | -21.6 | -42.0 | -- | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Star Imaging and Path Lab
|
52.4 | 91.4 | 83.5 | 16.0 | -- | 40.6 | 5.7 | 0.8 |
| 1,328.7 | 22,273.1 | 2,662.8 | 533.1 | 22.9 | 24.1 | 42.2 | 8.7 | |
| 626.3 | 25,054.7 | 3,626.9 | 315.0 | 15.0 | 13.3 | 83.3 | 10.8 | |
| 550.5 | 1,777.8 | 766.3 | 80.5 | 15.7 | 8.9 | 22.1 | 1.9 | |
| 421.8 | 8,768.9 | 1,566.5 | 169.5 | 14.8 | 12.7 | 52.1 | 5.8 | |
| 528.6 | 5,290.0 | 755.8 | 67.1 | -- | 13.8 | 78.8 | 5.5 | |
| 271.7 | 856.3 | 1,231.3 | 29.1 | -4.7 | 4 | 32.9 | 1.3 | |
| 245.0 | 1,273.4 | 294.1 | 32.4 | 17.4 | 15.1 | 38.2 | 5.4 | |
| 366.0 | 5,827.8 | 792.3 | 135.5 | 23.5 | 26.4 | 42.3 | 8.7 | |
| 897.1 | 8,662.4 | 768.1 | 159.9 | 29.2 | 19.3 | 54.3 | 9.5 |
No Review & Analysis are available.
--
Incorporated
2004
Chairman
Pawan Gupta
Managing Director
Pawan Gupta
Headquarters
New Delhi, Delhi
Website
Looking for more details about Star Imaging and Path Lab Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Star Imaging and Path Lab Ltd is ₹52.44 (BSE) as of 02-Apr-2026 IST. Star Imaging and Path Lab Ltd has given a return of --% in the last 1 years.
The P/E ratio of Star Imaging and Path Lab Ltd is 5.74 times as on 02-Apr-2026, a 88 discount to its peers’ median range of 47.23 times.
The P/B ratio of Star Imaging and Path Lab Ltd is 0.79 times as on 02-Apr-2026, a 88 discount to its peers’ median range of 6.45 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Star Imaging and Path Lab Ltd are Rs 152.00 and Rs 46.00 as of 05-Apr-2026.
Star Imaging and Path Lab Ltd has a market capitalisation of ₹ 91 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Star Imaging and Path Lab Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.08
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.